Loading...
Loading...
GUIDED THERAPEUTICS INC
GUIDED THERAPEUTICS INC. Spoken Alpha tracks GTHP's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks GTHP's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 70% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for GTHP.
curl https://api.spokenalpha.com/v1/companies/GTHP| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $5.60 | $4.02 | +39.2% | +2.0% | -0.7% |
| Q4 FY2026 | $5.94 | $4.02 | +47.8% | -3.6% | -5.3% |
| Q3 FY2026 | $5.73 | $4.14 | +38.3% | +1.0% | +2.4% |
| Q2 FY2026 | $5.77 | $4.16 | +38.8% | +5.1% | +2.6% |
| Q1 FY2025 | $5.58 | $3.91 | +42.6% | +2.6% | +5.3% |
| Q4 FY2025 | $5.75 | $3.98 | +44.5% | +3.8% | +1.2% |
| Q3 FY2025 | $5.82 | $4.07 | +43.1% | -1.1% | -1.0% |
| Q2 FY2025 | $5.34 | $4.02 | +32.8% | +3.2% | +0.3% |
| Q1 FY2024 | $6.09 | $4.20 | +45.1% | +3.1% | +0.9% |
| Q4 FY2024 | $5.68 | $4.17 | +36.1% | -5.5% | -4.2% |